superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2009-12-31
- Valid until
- 2010-12-31
- Published
- 2010-02-19
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 35,166,721,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Abbott Laboratories revenue: 30,764,707,000 United States dollar", as of 2009-12-31 (until 2010-12-31). Claim clm_BF21BA903CA4, https://asof.is/claim/clm_BF21BA903CA4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000104746910001018/0001047469-10-001018-index.htm.
APA
AsOf. (2009). Abbott Laboratories revenue: 30,764,707,000 United States dollar (as of 2009-12-31 (until 2010-12-31)) [Record clm_BF21BA903CA4]. Retrieved November 9, 2026, from https://asof.is/claim/clm_BF21BA903CA4 (source: https://www.sec.gov/Archives/edgar/data/1800/000104746910001018/0001047469-10-001018-index.htm)
BibTeX
@misc{asof_clm_BF21BA903CA4,
author = {AsOf},
title = {Abbott Laboratories revenue: 30,764,707,000 United States dollar},
year = {2009},
howpublished = {\url{https://asof.is/claim/clm_BF21BA903CA4}},
note = {Claim clm\_BF21BA903CA4, as of 2009-12-31 (until 2010-12-31); source: https://www.sec.gov/Archives/edgar/data/1800/000104746910001018/0001047469-10-001018-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_BF21BA903CA4.md/v1/claims/clm_BF21BA903CA4submit a correction